Cardiol Therapeutics Files US$150M Shelf Prospectus
Toronto, Ontario, Canada, September 10, 2026 Cardiol Therapeutics Inc. has filed a US$150 million preliminary short form base shelf...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Toronto, Ontario, Canada, September 10, 2026 Cardiol Therapeutics Inc. has filed a US$150 million preliminary short form base shelf...
